John M Allen

John M Allen, Pharm.D., BCPS, BCCCP, FCCM, FCCP

Associate Dean And Clinical Assistant Professor

Department: Pharmacotherapy & Translational Research
Business Phone: (407) 313-7006
Business Email: john.allen@cop.ufl.edu

About John M Allen

John M. Allen, Pharm.D., BCPS, BCCCP, FCCM, FCCP is the UF College of Pharmacy’s associate dean for diversity, inclusion and health equity and a clinical assistant professor at the college’s Orlando campus. Born and raised in Philadelphia, Dr. Allen joined the college in 2018. Dr. Allen’s professional areas of interest include health equity, antimicrobial stewardship in the intensive care unit, antibiotic dosing in sepsis, and treatment of multi-drug resistant infections in critically ill patients.

Dr. Allen graduated with his Doctor of Pharmacy degree from Florida A&M University in Tallahassee, FL. He then completed a PGY-1 residency, followed by a PGY-2 Critical Care residency at Tampa General Hospital, in Tampa, FL. Dr. Allen is a dual board-certified pharmacist in critical care, and pharmacotherapy.

Dr. Allen is an active member of the Society of Critical Care Medicine, American College of Clinical Pharmacy, Society of Infectious Diseases Pharmacists and the Florida Society of Health-System Pharmacists and has been appointed to committees within all of these organizations. In 2017, Dr. Allen received the prestigious honor of induction as a Fellow of the American College of Critical Care Medicine, which honors individuals whose achievements and contributions demonstrate personal commitment to critical care excellence, a distinction at the time of his induction bestowed upon seven pharmacists in the state of Florida.

Prior to his appointment at the University of Florida, Dr. Allen has held a variety of diverse administrative experiences including serving as a pharmacy clinical coordinator, pharmacy residency program director, and director of infectious diseases pharmacy for a 16-hospital system. In his free time, Dr. Allen enjoys watching anything with four wheels going fast, traveling, and spending time with his wife and three children.

Accomplishments

Presidential Citation
2021 · Society of Critical Care Medicine
Outstanding Student Organization Advisor
2020 · University of Florida College of Pharmacy
Exemplary Teacher Award
2020 · University of Florida College of Pharmacy
Elected Fellow
2020 · American College of Clinical Pharmacy
Mentored Research Investigator Training (MeRIT) Scholarship Award
2019 · American College of Clinical Pharmacy Critical Care Practice Research Network
Presidential Citation
2018 · Society of Critical Care Medicine
Elected Fellow
2017 · American College of Critical Care Medicine
Presidential Citation
2015 · Society of Critical Care Medicine

Board Certifications

  • Board Certified Critical Care Pharmacist
    Board of Pharmacy Specialties
  • Board Certified Pharmacotherapy Specialist
    Board of Pharmacy Specialties

Research Profile

Open Researcher and Contributor ID (ORCID)

0000-0002-0033-4508

Areas of Interest
  • Antibiotic resistance
  • Health Disparities
  • Sepsis

Publications

2021
Impact of supplemental individual verbal defense on confidence, engagement, and performance in a team-based learning therapeutics course.
Currents in pharmacy teaching & learning. 13(2):152-158 [DOI] 10.1016/j.cptl.2020.09.010. [PMID] 33454072.
2021
Ten recommendations to increase Black representation within pharmacy organization leaderships.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. [DOI] 10.1093/ajhp/zxab077. [PMID] 33611345.
2020
COVID-19 Therapeutics: Making Sense of It All.
AACN advanced critical care. 31(3):239-249 [DOI] 10.4037/aacnacc2020792. [PMID] 32668460.
2019
Angiotensin II: A New Vasopressor for the Treatment of Distributive Shock.
Clinical therapeutics. 41(12):2594-2610 [DOI] 10.1016/j.clinthera.2019.09.014. [PMID] 31668356.
2019
Cefazolin Versus Anti-Staphylococcal Penicillins for the Treatment of Patients with Methicillin-Susceptible Staphylococcus aureus Infection: A Meta-Analysis with Trial Sequential Analysis.
Infectious diseases and therapy. 8(4):671-686 [DOI] 10.1007/s40121-019-00259-4. [PMID] 31392580.
2019
Effect of prescriber peer comparison reports on fluoroquinolone use across a 16-facility community hospital system
Journal of the American College of Clinical Pharmacy. 2(5):502-508 [DOI] 10.1002/jac5.1106.
2019
Recent Updates in the Pharmacological Management of Sepsis and Septic Shock: A Systematic Review Focused on Fluid Resuscitation, Vasopressors, and Corticosteroids.
The Annals of pharmacotherapy. 53(4):385-395 [DOI] 10.1177/1060028018812940. [PMID] 30404539.
2015
Green urine in the intensive care unit: is this clinically relevant?
The American surgeon. 81(1):E32-3 [PMID] 25569058.
View on: PubMed
2015
Major publications in the critical care pharmacotherapy literature: January-December 2013.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 72(3):224-36 [DOI] 10.2146/ajhp140241. [PMID] 25596607.
2015
Standard dosing of enoxaparin for venous thromboembolism prophylaxis is not sufficient for most patients within a trauma intensive care unit
American Surgeon. 81:889-892
2014
Pharmacogenomics in the intensive care unit: focus on potential implications for clinical practice
Recent Patents on Biotechnology. 8:116-122
2014
Understanding vasoactive medications: focus on pharmacology and effective titration
Journal of Infusion Nursing. 37:82-86
2013
Improved outcome of ventilator-associated pneumonia caused by methicillin-resistant Staphylococcus aureus in a trauma population
American Journal of Surgery. 205:255-258
2013
Ventriculoperitoneal shunt infections in adult patients.
AACN advanced critical care. 24(1):6-12; quiz 13 [DOI] 10.1097/NCI.0b013e31827be1d1. [PMID] 23343806.
2012
Prevention, recognition, and management of delirium in the intensive care unit
AACN advanced critical care. 23:5-11
2012
Vasoactive substances and their effects on nutrition in the critically ill patient
Nutrition in Clinical Practice. 27:335-339
2011
Evaluation of recombinant factor VIIa off-label use at an acute care hospital with established guidelines for use
Hospital pharmacy (Philadelphia, Pa.). 46:173-179

Grants

Sep 2018 ACTIVE
2/3 Florida-California Cancer Research, Education & Engagement (CaRE2) Health Equity Center
Role: Co-Investigator
Funding: NATL INST OF HLTH NCI

Education

Post Graduate Year 2 (PGY-2) Critical Care Pharmacy Residency
2010-2011 · Tampa General Hospital
Post Graduate Year 1 (PGY-1) Pharmacy Residency
2009-2010 · Tampa General Hospital
Pharm.D.
2003-2009 · Florida A&M University

Teaching Profile

Courses Taught
2018,2020-2021
PHA5878C Pt Care 3: Cv and Pulm
2018-2021
PHA5782C Patient Care 2
2019-2020
PHA5876C Pt Care 8 Complex Pts
2019
PHA5607 Crit Care Pharmacy
2019
PHA5787C Pt Care 5: Endo
2019
PHA5164L Prof Skills Lab Iv
2018
PHA5163L Prac Skills Lab III
2018
PHA5788 Pharmacotherapy 6

Contact Details

Phones:
Business:
(407) 313-7006
Emails: